Hocher, Berthold
Tsuprykov, Oleg
Article History
First Online: 9 October 2017
Competing interests
: B.H. is a consultant for Boehringer Ingelheim on the development of dipeptidyl peptidase 4 (DPP4) inhibitors and has received research funding from this company for investigation of the renal effects of the DPP4 inhibitor linagliptin. O.T. declares no competing interests.